Skip to main content
. Author manuscript; available in PMC: 2015 Feb 19.
Published in final edited form as: Exp Clin Psychopharmacol. 2014 Feb;22(1):75–85. doi: 10.1037/a0034863

Table 2.

Urinalysis, Workplace, and HIV-risk Behavior Outcomes

Abstinence
and Work
(n=16)
Work Only
(n=15)
No Vouchers
(n=15)
P OR (95% CI)
Urinalysis Outcomesa
 Urinalysis Samples Provided (%) 58 76 64 0.51 0.79 (0.25 - 2.51)
 Opiate-negative Urinalysis (%)
  Intake 7 14 7 0.78 --
  Interventionb 45 31 42 0.63 0.57 (0.17- 1.90)
  12-month follow-up 62 33 27 0.99 --
 Cocaine-negative Urinalysis (%)
  Intake 7 20 0 0.16 --
  Interventionb 52 27 42 0.22 0.36 (0.11 - 1.15)
  12-month follow-up 50 40 47 0.85 --
 Opiate and Cocaine-negative Urinalysis (%)
  Intake 0 7 0 0.37 --
  Interventionb 42 24 36 0.39 0.44 (0.13- 1.49)
  12-month follow-up 50 20 27 0.17 --
Workplace Outcomes
 Days Attended Workplace (%) 12 27 5 0.02 6.45 (1.41-29.32)
HIV-related Risk Behaviors
 Injected drugs (%)
  Intake 100 100 92 0.29
  Intervention 54 74 49 0.14 0.49 (0.13- 1.30)
  12-month follow-up 40 69 44 0.31
 Shared needles (%)
  Intake 27 13 25 0.63
  Intervention 12 1 3 0.72 1.00 (0.07- 14.92)
  12-month follow-up 0 0 0 0.99
 Used condoms (%)
  Intake 6 13 0 0.35
  Intervention 7 18 1 0.06 0.35 (0.10 - 1.26)
  12-month follow-up 0 23 0 0.09
a

= Missing samples have been interpolated

b

= Intervention data based on thrice-weekly testing

= Significant difference between Work Only and No Voucher groups